Category: Vaccines

Posted on

CV #37(H): BCCDC Admitted A Year Ago PCR Tests Don’t Work As Advertised

https://canucklaw.ca/wp-content/uploads/2021/01/BC-COVID19_InterpretingTesting_Results_NAT_PCR.pdf
http://www.bccdc.ca/Health-Professionals-Site/Documents/COVID19_InterpretingTesting_Results_NAT_PCR.pdf
https://www.cpsbc.ca/for-physicians/college-connector/2020-V08-02/04

1. How does the test work?
The NAT works by detecting RNA specific to the SARS-CoV-2 virus that causes COVID-19 infection, after RNA has been extracted from the specimen and then amplified in the laboratory. NATs are typically performed on nasopharyngeal swabs, but the test can also be done on other sample types such as throat swabs, saliva, sputum, tracheal aspirates, and broncho-alveolar lavage (BAL) specimens.
.
The NAT has a high analytical sensitivity (i.e., it works well at detecting the virus when the virus is present). The NAT can potentially detect as few as 10-100 copies of viral RNA per mL in a respiratory sample. Note that this is not the same as clinical sensitivity of NAT for detection of COVID-19 infection, which is unknown at this time (see #5 below)

2. What do the test results mean?
 Positive: Viral RNA is detected by NAT and this means that the patient is confirmed to have COVID-19 infection.
A positive NAT does not necessarily mean that a patient is infectious, as viral RNA can be shed in the respiratory tract for weeks but cultivatable (live) virus is typically not detected beyond 8 to 10 days after symptom onset.
 Negative: Viral RNA is not detected in the sample. However, a negative test result does not totally rule out COVID-19 infection as there may be reasons beyond test performance that can result in a lack of RNA detection in patients with COVID-19 infection (false negatives; see below).
 Indeterminate: The NAT result is outside the validated range of the test (i.e., RNA concentration is below the
limit of detection, or a non-specific reaction), or this might occur when the sample collected is of poor quality
(i.e., does not contain a sufficient amount of human cells). Indeterminate results do not rule in or rule out infection.
.
Overall, clinical judgement remains important in determining the implications of NAT test results, and whether a repeat test is indicated for negative or indeterminate results (for example, if the patient’s recent exposures or clinical presentation suggest COVID-19 infection is likely, diagnostic tests for other respiratory pathogens remain negative, or there is worsening of symptoms). For clinical guidance including testing and specimen collection, please refer to COVID-19 testing guidelines for British Columbia.

5. What is the clinical sensitivity of the NAT test?
A statistic commonly quoted is that there is a 30% chance of a false negative result for a NAT test in a patient with COVID-19 infection (i.e., a 70% sensitivity). These and other similar estimates are based on a small number studies that compared the correlation between CT scan findings suggestive of COVID-19 infection to NAT on upper respiratory tract specimens. In these studies, 20-30% of people with a positive CT scan result had negative NAT results – and as discussed above a number of factors can contribute to false negative results. CT scan is not a gold standard for diagnosis of COVID-19 infection, and CT scan cannot differentiate amongst the many microbiological causes of pneumonia.
.
Ultimately, for COVID-19 testing, there is currently no gold standard, and the overall clinical sensitivity and specificity of NAT in patients with COVID-19 infection is unknown (i.e., how well NAT results correlate with clinical infection, “true positivity” or “true negativity” rate).

Some points to take away
-Detecing RNA does not mean infection
-Error rate in infection detection is unknown.
-Positive test is meaningless
-Negative test is meaningless
-Can’t distinguish with many microbial causes of pneumonia
-30% false negative rate just a “commonly quoted statistic”
-Actual accuracy rate unknown

As for the “deaths due to Covid” perhaps check out the guidelines passed down College of Physicians and Surgeons of British Columbia:

1. Recording COVID-19 on the medical certificate of cause of death

COVID-19 should be recorded on the medical certificate of cause of death for all decedents where the disease caused, or is assumed to have caused, or contributed to death.

In other words, just make it up.

Posted on

Another Toronto Court Challenge, But Will This One Actually Go Anywhere?

There was an online announcement of a Notice of Application filed in the Toronto Branch of Ontario Superior Court, Civil Division. Predictably, it caused a buzz in the alternative media. Several commented that it was disappointing the mainstream outlets chose not to cover it.

While that is a valid point, there is another one to raise: how come other complaints have dropped off of people’s radars? There was one filed in October 2019 that is collecting dust 18 months later. There is also a high profile suit filed July 2020 with no defenses submitted almost a year later. True, there was a temporary moratorium on filing deadlines, but that lapsed September 14, 2020. There doesn’t appear to have been any attempt to either force that case ahead, or seek default judgement.

The average person may not know this, but it’s quite easy to search for a case in Ontario and see what progress, if any, has been made. If Parties aren’t even represented, that can also be found out.

Despite there being no movement in those cases, a defamation lawsuit was filed in December 2020. Interesting how actual human rights violations are worth only $11 million, but mean words on Twitter is worth $12.75 million. Perhaps there is some deeper insight that isn’t obvious.

Now, what people choose to do in their private lives is their business. That being said, when asking for donations from the public to finance a lawsuit, it’s worthwhile to ensure the money is going where it’s supposed to be.

One example last year was Action4Canada/Liberty Talk raising money for the promise of a lawsuit in B.C., against Bonnie Henry. Now, the fundraising started in September 2020 (if not earlier), so that has been 8 months now. The promised lawsuit has not materialized. Odessa Orlewicz has spoken about pocketing 25% of it.

It sounds great (on the surface) that another challenge was launched. However, it must be asked: will anything become of it? Or will it fade away, like its predecessors?

On the topic of covering court cases: it’s worth pointing out that various Libel & Slander Acts provide a number of defenses for people reporting on them. These include truth, opinion, public interest, and acting in good faith. Also, there are anti-SLAPP laws (strategic lawsuits against public participation), that ensure reporters and journalists will have a wide breadth to cover important events. For anyone wanting to publish information on court cases, this is important to know.

Posted on

Healthcare Of Ontario Pension Plan (HOOPP) Owns Stock In Vaccines & Masks Being Pushed

The Ontario Science Table lists groups in the health care sector as its partners. Whether or not the individual members support this, and to what extent, the pensions of a lot of people are tied up in promoting their agenda.

HOOPP, the Healthcare of Ontario Pension Plan has some interesting medical holdings. This is at least according the SEC, or U.S. Securities and Exchanges Commission. While there is nothing inherently bad in investing in your own field, it will be driven by the way you want it to go.

The fund claims to have over $100 billion in net assets, or equity. Fair enough, let’s take a look at where some of that money is.

COMPANY AMOUNT
1Life Healthcare $540,000
3M Co. $462,000
Alexion Pharmaceuticals $34,891,000
Alnylam Pharmaceuticals $213,000
Alpha Healthcare Acquisition Corp $2,232,000
Amplitude Health Care Acquisition $930,000
Bausch Health Cos $2,366,000
Biogen Inc. $235,000
CVS Health Corp $32,871
Cytomx Therapeutics Inc. $835,000
Deerfield Healthcare Technology Acquisition $2,696,000
DFP Healthcare Acquisition $3,633,000
Gilead Sciences $6,420,000
HCA Healthcare $142,000
Healthcare Merger Corp. $1,019,000
Jazz Pharmaceuticals PLC $3,538,000
Johnson & Johnson $34,401,000
Livongo Health Inc. $6,169,000
Merck & Co. $6,221,000
Pfizer $38,467,000
Regeneron Pharmaceuticals $1,052,000

The individual companies weren’t named in the HOOPP paperwork, so a visit to the SEC was needed for that. For reference, Gilead is the manufacturer of Veklury, also known as Remdesivir, a drug (not a vaccine) to counter Covid-19. It was given interim authorization to be used in Canada. Janssen (which is owned by Johnson & Johnson) also has an authorized “vaccine” in Canada. So does Pfizer, which is partnered with BioNTech. Yes, these are the same companies.

As for the next group, this is on the list of things that will make you go “hmmm”. If health care workers in Ontario were expecting, or wanting, a shutdown of society, these would be the companies to invest in.

A serious question: does it come across as a conflict of interest when health care workers are pushing pharmaceuticals which their pension plans own stock in? And it gets stranger.

COMPANY AMOUNT
Alibaba Group Holdings $730,000,000
Alphabet Inc. $4,799,000
Amazon $18,848
Beyond Meat Inc. $151,000
Blackline Software $16,000
Blackrock $85,000
Blackstone Group $625,000
Broadcom Inc. $181,000
Coca Cola Co. $58,552,000
Dish Network Corporation $89,000
E-Bay $101,000
Facebook $24,022,000
Goldman Sachs $15,978,000
Grid Dynamics Inc. $4,676,000
Mastercard $427,644,000
Microsoft Corp. $298,081
Netflix $335,000
Nike $2,354
PayPal Holdings $378,000
Salesforce $2,746,000
Shaw Communications $6,386,000
Shopify $50,537,000
Starbucks $11,065,000
Visa $1,802,000
Walmart $13,148,000
Zoom Communications $216,000

HOOPP seems to be investing in everything that we need in order to have a cashless society, working from home, and an abundance of pharmaceuticals. But that’s probably just a coincidence.

While most of the profiles of the HOOPP leadership were privatized, a few were in the open. Some interesting details revealed in them.

Tanya Pereira is the Senior Director of Operations at HOOPP. She is also a Strategic Advisor at Andone Pharmaceuticals, during that same time period.

John Watson is the Director of Operations Support at HOOPP. He has also been charge of other pension plans. Early in his career, he was a records supervisor at Sick Kids Hospital Toronto, which gets significant funding from the Gates Foundation.

HOOPP claims to be pushing the ESG/green agenda pretty hard. So expect that they’ll only be investing in such companies that “appear” to be green, regardless of whether or not they actually are green. They sing the praises about sustainability and climate change. Most people have heard it all before.

As for the HOOPP owning stock in these vaccines and masks, and their members pushing them on the public, that is downright shady, to say the least. True, it’s the doctors and nurses themselves who market it to the lay person, but how does this look?

Is this ancient? According to the SEC, it covers the period up to December 31, 2020, and was filed on March 1, 2021. Now, it’s possible that these shares have since been sold, but the first interim authorizations were coming out before then. Again, how does it look?

IMPORTANT LINKS
(1) https://hoopp.com/
(2) https://hoopp.com/about-hoopp
(3) https://hoopp.com/investments/pension-plan-performance-and-hoopp-annual-report
(4) https://hoopp.com/about-hoopp/pension-leadership
(5) https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/list-drugs.html
(6) https://covid-vaccine.canada.ca/veklury/product-details
(7) https://covid-vaccine.canada.ca/janssen-covid-19-vaccine/product-details
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/0001535845-20-000007-index.htm
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/xslForm13F_X01/SEC13F09_2020.xml
https://archive.is/Kqazd

EARLIER IN THIS SERIES
(a) Michael Warner Financially Benefits From Prolonged Lockdowns
(b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
(c) OST, Monopoly From The University Of Toronto Connected
(d) OST, University Of Toronto, Look At Their Members And Partners
(e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
(f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
(g) OST UofT Prelude Actually Set Out In May 2019
(h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
(i) OST: Como Foundation Gives Trillium Health Partners $5M
(j) OST: Current PHO Officials Also Sitting On As Partners
(k) OST: Canadian Agency For Drugs & Technologies In Health; pCPA
(l) OST: Centre For Effective Practice Gets Money From Lockdown
(m) OST: Cochrane Canada; WHO; McMaster University
(n) OST: SPOR Evidence Alliance Gets Funding From WHO

Posted on

OST; WHO; Canadian Agency for Drugs and Technologies in Health (CADTH), Pan-Canadian Pharmaceutical Alliance

The Canadian Agency for Drugs and Technologies in Health (CADTH), is a partner of the Ontario Science Table, or OST. However, CADTH is also a working group for the World Health Organization, Health Evidence Network. Now, OST “claims” to be a neutral and independent body giving scientific and medical advice. Question, is CADTH compromised, or can this do really serve 2 (or more) masters?

The Health Evidence Network describes itself in the following way:

Recognizing that public health, health care and health systems policy-makers need access to timely, independent and reliable health information for decision-making, WHO/Europe started HEN in 2003. It acts as a platform, providing evidence in multiple formats to help decision-making.

The Health Evidence Network also claims to be independent, much the way OST does. Interestingly, they always have the exact same recommendations to make.

Previously Theresa Tam got flack for being on a World Health Organization Committee, while simultaneously claiming to represent Canada as the Public Health Officer. It seems these kinds of conflicts of interest are normal, and not the exception.

CADTH, the Canadian Agency for Drugs and Technologies in Health, claims to be

an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Created in 1989 by Canada’s federal, provincial, and territorial governments, CADTH was born from the idea that Canada needs a coordinated approach to assessing health technologies. The result was an organization that harnesses Canadian expertise from every region and produces evidence-informed solutions that benefit patients in jurisdictions across the country.

CADTH claims to be independent, just like OST claims to be independent. The WHO Health Evidence Network also says that it’s an independent entity. Keep that in mind, as it will become important later on. Now, who actually runs CADTH?

  • David Agnew: held the position of President and CEO of UNICEF Canada, and was the first head of the organization recruited from outside the international development sector. He is the past Chair of Sunnybrook Health Sciences Centre and of Colleges Ontario. He also serves on numerous other boards and committees, including the Toronto Region Immigrant Employment Council, the Council on Foreign Relations’ Higher Education Working Group on Global Issues, the Sichuan University International Advisory Board, the CivicAction Steering Committee and the Canadian Ditchley Foundation Advisory Board. He is a former member of the federal government’s Science, Technology, and Innovation Council, a former director of ventureLAB and the Empire Club of Canada, and has served on the campaign cabinets of the United Way in Toronto and Peel.
  • Marcel Saulnier, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada
  • Western Provinces, Mitch Moneo, Assistant Deputy Minister, Pharmaceutical Services Division, Ministry of Health, British Columbia
  • Mark Wyatt, Assistant Deputy Minister, Saskatchewan Ministry of Health
  • Territories, Stephen Samis, Deputy Minister, Health and Social Services, Government of Yukon
  • Ontario, Patrick Dicerni, Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs
  • Atlantic Provinces, Jeannine Lagassé, Associate Deputy Minister of Health and Wellness, Province of Nova Scotia.
  • Karen Stone, Deputy Minister of Health and Community Services (NL)
  • Health Systems, Dr. Brendan Carr, President and CEO of the Nova Scotia Health Authority

The Board of Directors of CADTH primarily is made up of high level bureaucrats in Canada, such as Associate Deputy Ministers. Far from being independent, this board is in fact connected to Provincial and Federal Governments.

  • drugs
  • diagnostic tests
  • medical, dental, and surgical devices and procedures

CADTH makes recommendations whether to accept certain medical devices and procedures. They also make recommendations on pharmaceuticals. This is interesting, considering that they don’t seem to do any research themselves. In fact, looking up the term “gene therapy” nets a lot of results.

Strange, because aren’t the Pfizer and Moderna mRNA “vaccines” really just a form of gene replacement therapy? It seems this technology has been around for a while.

Although this may seem harmless enough, there is another aspect to what these Provincial bureaucrats are doing. It’s not only that they want to review and make recommendations, but they want to PROMOTE cheap pharmaceuticals as well.

The pan-Canadian Pharmaceutical Alliance (pCPA) is an alliance of the provincial, territorial and federal governments that collaborates on a range of public drug plan initiatives to increase and manage access to clinically effective and affordable drug treatments.

One of pCPA’s key roles is to conduct joint negotiations for brand name and generic drugs in Canada in order to achieve greater value for publicly funded drug programs and patients through its combined negotiating power. Its objectives are to:

  • increase access to clinically effective and cost-effective drug treatment options;
  • achieve consistent and lower drug costs for participating jurisdictions;
  • reduce duplication of effort and improve use of resources; and
  • improve consistency of decisions among participating jurisdictions.

    • (Alberta) Chad Mitchell, Assistant Deputy Minister
    (British Columbia) Mitch Moneo, Assistant Deputy Minister (Vice-Chair, Acting)
    (Manitoba) Teresa Mrozek, (A) Assistant Deputy Minister
    (New Brunswick) Mark Wies, Assistant Deputy Minister
    (Newfoundland & Labrador) John McGrath, (A) Assistant Deputy Minister
    (Northwest Territories) Derek Elkin, Assistant Deputy Minister
    (Nova Scotia) Natalie Borden, Executive Director
    (Nunavut) Donna Mulvey, Territorial Director
    (Ontario) Patrick Dicerni, Assistant Deputy Minister; Executive Officer
    (Prince Edward Island) Lori Ellis, Director of Health Workforce Planning and Pharmacy
    (Quebec) Lucie Opatrny, Assistant Deputy Minister
    (Saskatchewan) Mark Wyatt, Assistant Deputy Minister (Chair)
    (Yukon) Amy Riske, Assistant Deputy Minister
    (Federal) Scott Doidge, Director General

    Notice anything? Just like with CADTH, the pan-Canadian Pharmaceutical Alliance is also run by top bureaucrats in the Governments. In fact, Mitch Moneo of B.C., and Mark Wyatt of Saskatchewan sit on both groups. the goal of this group is getting cheap, generic drugs available to all Canadians.

    Now, these bureaucrats, and their colleagues, are also involved with the Canadian Agency for Drugs and Technologies in Health, which approves drugs, procedures, and medical devices.

    And CADTH is a partner of the Ontario Science Table, which is pushing: mass vaccination, drugs for other health issues, mandatory masks, and lockdowns which will drive up the use of internet and virtual health care.

    The pCPA site explains the process like this:
    Health Canada reviews the drugs, which is not the same as actually testing them. Then CADTH and INESSS (the Quebec counterpart), review it to see if this is a cost effective way to go. Then pCPA tries to negotiate for cheaper and more affordable drug prices. Eventually it gets worked into public and private drug plans.

    Back to the original point: the Ontario Science Table claims to be an independent group. But it’s partnered with (among others) CADTH, who plays a major role in advancing big pharma in Canada.

    IMPORTANT LINKS
    (a) https://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/health-evidence-network-hen/technical-members/current-technical-members/canadian-agency-for-drugs-and-technologies-in-health-cadth,-canada
    (b) https://covid19-sciencetable.ca/our-partners/
    (c) https://www.cadth.ca/about-cadth
    (d) https://www.cadth.ca/about-cadth/who-we-are/board-of-directors
    (e) https://www.pcpacanada.ca/
    (f) https://www.pcpacanada.ca/governance
    (g) https://www.pcpacanada.ca/faq
    (h) https://www.pcpacanada.ca/about

    EARLIER IN THIS SERIES
    (a) Michael Warner Financially Benefits From Prolonged Lockdowns
    (b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
    (c) OST, Monopoly From The University Of Toronto Connected
    (d) OST, University Of Toronto, Look At Their Members And Partners
    (e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
    (f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
    (g) OST UofT Prelude Actually Set Out In May 2019
    (h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
    (i) Como Foundation Gives Trillium Health Partners $5M
    (j) Current PHO Officials Also Sitting On Ontario Science Table

    Posted on

    Public Health Ontario A Semi-Autonomous Corporation, Whose Leaders Sit With ON Science Table

    According to the Ontario Agency for Health Protection and Promotion Act, 2007, the Ontario Agency for Health Protection and Promotion was created, which is now referred to as Public Health Ontario. The timing is interesting, given that its creation aligns with the 2005 Quarantine Act, which itself is the result of the 3rd Edition of the International Health Regulations from the World Health Organization.

    For some background information, here is more on the WHO-IHR, the Quarantine Act, and Ontario‘s own Health Act. It’s worth also addressing PHAC, and its self-proclaimed advisor, Robert Steiner, who also sits on OST. These are not independent events, but are directly linked.

    This entity (referred to as Public Health Ontario, or PHO), is set up and structured as a corporation. It’s a Crown Corporation, mostly autonomous from the Government.

    Powers
    7 (1) Except as limited by this Act, the Corporation has the capacity, rights and powers of a natural person for carrying out its objects. 2007, c. 10, Sched. K, s. 7 (1).

    This group is to have the same rights and powers as an actual person which is not weird at all. The Act also indemnifies any employees or officers or directors from any liability, as long as they claim to be acting in good faith.

    IMMUNITY AND UNPAID JUDGMENTS
    No actions or proceedings against Crown
    26 No proceeding for damages or otherwise shall be commenced against the Crown, the Minister or any person employed by the Crown with respect to any act done or omitted to be done or any decision of the Corporation, a director or officer of the Corporation, a member of a standing committee or a person employed by the Corporation. 2007, c. 10, Sched. K, s. 26.

    Immunity from civil action
    27 (1) No proceeding for damages or otherwise shall be commenced against the Minister, a director or officer of the Corporation, a member of a standing committee, or any person employed by the Crown or the Corporation, with respect to any act done or omitted to be done or any decision under this Act that is done in good faith in the execution or intended execution of a power or duty under this Act. 2007, c. 10, Sched. K, s. 27 (1); 2011, c. 1, Sched. 6, s. 7 (1).

    Nothing shows that people take responsibility for their actions quite like giving them a pass for the possible consequences. There are limited provisions for taking action against the Crown itself, but not members involved.

    Anyhow, that Act specifies that this corporation is to act as an autonomous and mostly independent group from the Government. This would be similar to Alberta Health Services operates.

    Now, PHO is structured as a corporation, and is designed to be an arm’s length operation from the Crown. Okay. But looking at who runs it, some familiar faces appear.

    • Brian Schwartz is Vice President of PHO
    • Vanessa Allen is Chief, Microbiology and Laboratory Science at PHO
    • Jessica Hopkins, Chief Health Protection and Emergency Preparedness Officer at PHO
    • Samir Patel, Deputy Chief, Microbiology and Laboratory Science at PHO

    Some interesting names in the Leadership of Public Health Ontario. Why should we care about who any of them are? There’s a really simple reason.

    In case it wasn’t clear, here is the point: several high ranking members of Public Health Ontario are also members of the Ontario Science Table. Keep in mind, the OST presents itself as neutral and independent expert advice. At the same time, officials from a Crown Corporation in that same Province are part of their organization.

    Considering that PHO functions as an extension of the World Health Organization, and implements their dictates, what kind of perspectives will these people bring to OST? Will they simply implement the same ideas, cloaked as “science”, or will they offer radically different policies? So far, it seems to be the former.

    When these people speak at OST events and gatherings, are they talking as scientists working independently for the health of Ontarians overall? Or, are they acting in the capacity of Public Health Ontario representatives? Unless the OST is an extension of PHO, there are bound to be conflicts of interest.

    It’s a bit like Theresa Tam, who has a page as the Public Health Officer of Canada, but who also as a page for a World Health Organization Advisory Committee. These people even use the same photographs.

    On a related note: Deputy Prime Minister, and Finance Minister, Chrystia Freeland is also a Trustee at the World Economic Forum. Other prominent politicians are also involved with that organization.

    The mess that is the covered before, and more is likely to be added. Far from being independent, OST is rotten to the core with conflicts of interests, and members who have side ventures.

    Do the OST and Trillium Health Partners really think that mask mandates are in the public’s best interest? Or did a $5 million donation from a mask manufacturer change their minds? Does Michael Warner‘s side business influence his support for lockdowns? What About Kumar Murty‘s business interests? Or Kwame McKenzie‘s 2017 Ontario UBI project?

    Final thoughts to readers in Ontario: do you have any clue who is really running health care in Ontario? Do you know who is actually running the Province? Who’s behind the martial law masked as medical necessity? Think Doug Ford or Christine Elliott are anything but puppets?

    Posted on

    Trillium Health Partners Gets $5 Million Grant From Company That Manufactures Face Masks

    Robert Reid is a member of the Ontario Science Table. He is also on the Senior Leadership Team of Trillium Health Partners. This is important because it sets up an interesting conflict of interest.

    Trillium is also a partner with the OST. So, when Reid is speaking, does he talk as a member of THP, or of the OST?

    For some perspective, the OST is already a questionable organization given: (a) rampant ties the the University of Toronto; (b) conflicts of interest with its partners and members; (c) the brainchild of PHAC works for them; (d) the former research chief of the Ontario UBI pilot project works for them; (e) the groundwork for OST was laid out in 2019; and (f) another member has a technology business that benefits from lockdowns.

    Ontario Deputy Medical Officer, Barbara Yaffe, is worth a long hard look. She has climbed the ranks and gained power, despite never practicing as a doctor. Another one is Michael Warner, who financially benefits from prolonged lockdowns. It’s also disturbing that NSERC/CIHR are actually paying people to act as vaccine salesmen, and cloak it as research.

    Now, what does all of this have to do with Reid and Trillium? On the surface, it looks like OST’s policies are once again being influenced by special interests. Back in September 2020, word of a $5 million donation from the Como Foundation was announced to the public.

    Mississauga, On (September 28, 2020) – When the pandemic hit, Max Cucchiella and his wife, Sarah Veinot, along with their family, gathered around the kitchen table in their Port Credit home to help their community. They started making non-medical masks with a clear vinyl insert in the centre, so that those who are deaf or hard of hearing and rely on lip-reading could rejoin the conversation during COVID-19. The lip-reading lens mask, called My Access Mask, is continually evolving with a commitment to quality, innovation and design. Demand took off and the family launched the Como Foundation, which today is announcing a $5 million gift to Trillium Health Partners Foundation with proceeds from mask sales. The generous donation will be used to support the redevelopment and expansion of Mississauga Hospital.

    The gift is the result of local innovation, benefitting not just those who are deaf or hard of hearing and Trillium Health Partners (THP), but also McRae Imaging, a local medium-sized business hurt by lost revenue as a result of COVID-19. McRae is now producing these novel masks at a commercial volume in Ontario and is listed on the province’s Workplace PPE Supplier Directory.

    How much is the mask industry thriving when a company can afford to cut a $5 million cheque, based on the proceeds from the last 8 months or so? Trillium Health Partners becomes relevant when you realize they are one of Ontario Science Table’s Partners. Not only is Robert Reid in management for THP, but he’s part of the OST as well. Trillium and Reid are in a position to press the Province for mask mandates.

    According to the Canada Revenue Agency, there are in fact 2 charities: (i) Trillium Health Partners; and (ii) Trillium Health Partners Foundation. The first is the teaching hospital aspect, and in 2019, it had about $1.2 billion in revenue. The second is the fundraising arm, and in 2019, it raised about $20 million.

    There is also an interesting question that needs to be asked: was any consideration given to the Como Foundation in return for this $5 million donation? In the world of public fundraising, it’s a bad idea to do anything that would harm a donor’s business. And declaring an end to the “pandemic”, or even just mask mandates, would certainly dry up a large part of the Como Foundation’s revenue.

    The Como Foundation makes a specialized product: see-through masks to help with people who have disabilities read lips and understand better. While there is definitely a benefit to this, it would have been considered a niche market until about a year ago, when masks became mandated.

    What was once a limited business has suddenly exploded in growth, thanks almost entirely to politicians imposing mask mandates on the public. In fact, Como’s business is doing so well, that they can make a $5 million donation to one of the Ontario Science Table’s partner organizations.

    Also in September 2020, Doug Ford gave the company a public shoutout, saying that these products were absolutely necessary. Now, his Government, encouraged by the Ontario Science Table, supports mandatory masks for the foreseeable future.

    Considering Health Canada only authorized their product in June 2020, they seem to have done remarkably well.

    What do you think? Does this donation from Como to Trillium come with any conditions, or any “understandings”? Or is it just a coincidence?

    (a) https://covid19-sciencetable.ca/about/
    (b) http://trilliumhealthpartners.ca/aboutus/Pages/Seniorleadership.aspx
    https://archive.is/1YZFu
    (c) https://trilliumgiving.ca/press-releases/como-gift/
    (d) https://www.thecomofoundation.ca/
    (e) https://www.youtube.com/watch?v=EDhBOmG5ZIc
    (f) https://www.thecomofoundation.ca/healthcanada
    Como Foundation Mask Health Authorization June 2020